CN102864085B - Rhodotorula minuta and separating and culturing method and application thereof - Google Patents

Rhodotorula minuta and separating and culturing method and application thereof Download PDF

Info

Publication number
CN102864085B
CN102864085B CN201210351821.0A CN201210351821A CN102864085B CN 102864085 B CN102864085 B CN 102864085B CN 201210351821 A CN201210351821 A CN 201210351821A CN 102864085 B CN102864085 B CN 102864085B
Authority
CN
China
Prior art keywords
rhodotorula
little
peptone
yeast
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210351821.0A
Other languages
Chinese (zh)
Other versions
CN102864085A (en
Inventor
廖万清
潘炜华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN201210351821.0A priority Critical patent/CN102864085B/en
Publication of CN102864085A publication Critical patent/CN102864085A/en
Application granted granted Critical
Publication of CN102864085B publication Critical patent/CN102864085B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to the technical field of living beings, in particular to rhodotorula minuta and a separating and culturing method and application thereof, and aims to separate, culture and purify a novel rhodotorula minuta strain which can cause human onychomycosis. The rhodotorula minuta is filed in CGMCC (China General Microbiological Culture Collection Center) by No.6019 on April 16, 2012. Morphological characteristics, culturing characteristics and carbon source utilization of the strain are researched further. The invention further provides the separating and culturing method of the strain and the application in screening antifungal drugs.

Description

A kind of little rhodotorula and isolation cultivation method and application
Technical field
The present invention relates to biological technical field, be specifically related to a kind of little rhodotorula and isolation cultivation method and application.
Background technology
Little rhodotorula is environment fungi; a few species is pathogenic bacterium; can cause immunosuppressed patient systemic infection (Thanos L; Mylona S; Kokkinaki A; Pomoni M, Tsiouris S, Batakis N.Multifocal skeletal tuberculosis with Rhodotorula minuta co-infection.Scand J Infect Dis.2006; 38 (4): 309-11.).
Mankind's tinea unguium is the fungi infestation of the deck He Jia undertissue that caused by pathogenic fungus.Tinea unguium mainly by Epidermophyton as trichophyton, alpha fungus etc., minority is caused by the filamentous fungus of yeast and non-dermatophytosis.Be a common disease, frequently-occurring disease.At present, clinical tinea unguium is divided into 5 types: type (endonyx onychomycosis) and first damage type (total distropic onychomycosis) entirely in shallow vindication A type (superficial white onychomycosis), position, distal side first mo(u)ld bottom half (distal and lateral subungual onychomycosis), near-end first mo(u)ld bottom half (proximal subungual onychomycosis), first.Can there is this disease in diabetes, immunocompromised patient and normal population bacterium.
There is no at present the little rhodotorula that the separated success of bibliographical information can cause mankind's tinea unguium, and the further investigation to the epidemiology of such little rhodotorula and mechanism of causing a disease.
Summary of the invention
The object of the invention is to little rhodotorula (Rhodotorula minuta) bacterial strain of new the caused mankind tinea unguium of separation and Culture purifying one strain, and its separation and Culture purification process is provided, and the application of this bacterial strain in screening antifungal drug.
The invention provides the little rhodotorula of a strain (Rhodotorula minuta), on April 16th, 2012, be preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC), address is: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, deposit number is CGMCCNo.6019.
This bacterial strain is separating obtained in a sick first of 15 years old immune normal female patient tinea unguium in Long March hospital dermatology department in 2011, through ITS order-checking and API 20C yeast identification kit, turns out to be little rhodotorula.
Little rhodotorula of the present invention (Rhodotorula minuta) bacterial strain CGMCC No.6019 belongs to Basidiomycota (Basidiomycota), load spore order (Sporidiales), Rhodotorula (Rhodotorula).
1. morphological specificity:
Sick first with 10%KOH, process after under light microscopic visible little, ellipsoideus yeast, 3.5-6.5 * 3.5 μ m.
2. cultural characteristic:
This bacterium can be leached substratum (MEA at Fructus Hordei Germinatus; Oxoid, Basingstoke, UK) upper 25 ℃ show as pink, smooth colony, clear border while cultivating.
3. utilization of carbon source:
Can assimilate glucose, sucrose, glycerine, succinate.Urea test is positive.
Described little rhodotorula ITS1,5.8S rDNA and ITS2 district amplification sequence measurement: adopt fungi universal primer
Upstream primer ITS5:5 '-GGAAGTAAAAGTCGTAACAAGG-3 ' (as shown in SEQ ID NO:1);
Downstream primer ITS4:5 '-TCCTCCGCTTATTGATATGC-3 ' (as shown in SEQ ID NO:2).
With genome amplification, PCR reaction system 50 μ L:10 * PCR buffer 5 μ L, 2.5mmol/L dNTP mixture 8 μ L, each 1ul of 10umol/L primer, template 2ul, Taq enzyme 0.5ul, sterilized water 32.5 μ L.Pcr amplification condition: 94 ℃ of denaturations 5 minutes, 94 ℃ of sex change 1 minute, 55 ℃ of annealing 1 minute, 70 ℃ are extended 2 minutes, 30 circulations; Preserve 10 minutes for 72 ℃.Gained amplified production is by twice of the two-way order-checking of ABI 3730DNA automatic sequencer.Sequencing result is as shown in SEQ ID NO:3; Sequencing result is carried out in NCBI website sequence alignment ( http:// blast.ncbi.nlm.nih.gov/Blast.cgi), with little rhodotorula CBS4407 than homology 99%.
The separation and Culture purification process of the little rhodotorula described in the present invention also provides, the method comprises:
Little rhodotorula is inoculated in sabouraud's agar flat board, and 25 ℃, growth in the 3rd day, obtains little rhodotorula bacterium colony;
The method also comprises cultivates and preserves step: from-70 ℃ of refrigerators, take out and preserve pipe, be positioned over immediately in 37 ℃ of water-baths and suitably shake 30s, open cryopreservation tube, get 1 transfering loop bacterium liquid and access on fresh Sharpe slant medium; During preservation, by bacterium liquid spread plate, after 48 hours, put into 4 ℃ of refrigerator short-term preservations or put into YEPD liquid nutrient medium-70 of containing 25% glycerine ℃ frozen.
Component and the weight percent of described Sharpe slant medium are as follows: glucose 4%, peptone 1%, agar 1.5%, and every 1000ml adds 200mg paraxin, standby after 121 ℃ of sterilizings in 10 minutes;
Component and the weight percent of described yeast leaching cream peptone (YEPD) liquid nutrient medium are as follows: 1% yeast leaches cream, 2% peptone, 2% glucose.
The present invention also provides the application of this bacterial strain in screening antifungal drug.
Described antifungal drug is specially anti-human class tinea unguium medicine.
With reference to M27-A3 method (Clinical Laboratory and Standards Institute.Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts.Approved standard M27-A3.Wayne, PA:National Committee for Clinical Laboratory Standards, 2008.), this little rhodotorula is measured the drug susceptibility of amphotericin b, flucytosine, fluconazole, itraconazole and voriconazole.Its MIC value is respectively <0.5, <4,16, <0.125, <1 μ g/mL.Little rhodotorula of the present invention can be used for screening new antifungal drug.
Accompanying drawing explanation
Fig. 1 is the KOH microscopy figure of the little rhodotorula of the present invention;
Fig. 2 is the onychonosus reason figure (PAS dyeing) of the little rhodotorula of the present invention.
Microbial preservation information: little rhodotorula (LWQ2010,), Classification And Nomenclature: little rhodotorula Rhodotorula minuta, on April 16th, 2012, be preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC), address is: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, deposit number is CGMCC No.6019.
Embodiment
Now in conjunction with the embodiments and accompanying drawing, the invention will be further described, but enforcement of the present invention is not limited in this.
Embodiment 1: little rhodotorula (Rhodotorula minuta) bacterial strain CGMCC No.6019
Little rhodotorula (LWQ2010), Classification And Nomenclature: little rhodotorula Rhodotorula minuta, belongs to Basidiomycota (Basidiomycota), load spore order (Sporidiales), Rhodotorula (Rhodotorula).
Bacterial strain of the present invention is identified by Shanghai Long March Hospital Dermatology Department separation and detection in tinea unguium disease first.On April 16th, 2012, be deposited in China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC), preservation registration number is CGMCCNO.6019.
1. morphological specificity:
Sick first with 10%KOH, process after under light microscopic visible little, ellipsoideus yeast, 3.5-6.5 * 3.5 μ m, as shown in Figure 1 and Figure 2.
2. cultural characteristic:
This bacterium can be leached substratum (MEA at Fructus Hordei Germinatus; Oxoid, Basingstoke, UK) upper 25 ℃ show as pink, smooth colony, clear border while cultivating.
3. utilization of carbon source:
Test method is referring to > such as > such as mycosis such as < such as < such as chief editor such as reference book: Liao Wanqing etc., People's Health Publisher, 1989.Can assimilate glucose, sucrose, glycerine, succinate.Urea test is positive.
4. the separation and Culture of bacterial strain and Techniques of preserving
The strain separating purification technique of little rhodotorula of the present invention comprises: little rhodotorula is inoculated in sabouraud's agar flat board (25 ℃), and growth in the 3rd day, obtains little rhodotorula bacterium colony.
Slant culture and the Techniques of preserving of described little rhodotorula comprise: from-70 ℃ of refrigerators, take out and preserve pipe, be positioned over immediately in 37 ℃ of water-baths and suitably shake 30s, open cryopreservation tube, get 1 transfering loop bacterium liquid and access on fresh Sharpe slant medium.Sabouraud culture medium formula: glucose 4%, peptone 1%, agar 1.5%, every 1000ml adds 200mg paraxin, standby after 121 ℃ of sterilizings in 10 minutes.During preservation, by bacterium liquid spread plate, after 48 hours, put into 4 ℃ of refrigerator short-term preservations or put into YEPD liquid nutrient medium-70 of containing 25% glycerine ℃ frozen.YEPD liquid culture based formulas: 1% yeast leaches cream, 2% peptone, 2% glucose.
5. fungi authenticate technology
Described little rhodotorula ITS1,5.8S rDNA and ITS2 district amplification sequence measurement: adopt fungi universal primer
Upstream primer ITS5:5 '-GGAAGTAAAAGTCGTAACAAGG-3 ' (as shown in SEQ ID NO:1);
Downstream primer ITS4:5 '-TCCTCCGCTTATTGATATGC-3 ' (as shown in SEQ ID NO:2).
With genome amplification, PCR reaction system 50 μ L:10 * PCR buffer 5 μ L, 2.5mmol/L dNTP mixture 8 μ L, each 1ul of 10umol/L primer, template 2ul, Taq enzyme 0.5ul, sterilized water 32.5 μ L.Pcr amplification condition: 94 ℃ of denaturations 5 minutes, 94 ℃ of sex change 1 minute, 55 ℃ of annealing 1 minute, 70 ℃ are extended 2 minutes, 30 circulations; Preserve 10 minutes for 72 ℃.Gained amplified production is by twice of the two-way order-checking of ABI 3730DNA automatic sequencer.Sequencing result:
GGGATTTTGCGTCTGATGATTTGAGATCTAAGCTTAAGTGCTATAAAGCGCATTAGAAGCACCTCTTATATTTGAAGAAGACGTCCTTAGCGAAATAATTATTACGCCAAGTCAAACCGTCTATTTCAATAGGGTTGCTCGTGTATTTCAGTTGAGCCGGCAATTACGCCGACAGACAACCATAATCCAAGCCCACGCCCATTTCATTACAAAATAGGGGGGTTGAGAGTTTCATGATACTCAAACAGACATACTCTTCGGAATACCAAAGAGTGCAAGGTGCGTTCAAAGATTCGATGATTCACTGAATTCTGCAATTCACATTACTTATCGCAATTCGCTGCGTTCTTCATCGATGCGAGAGCCAAGAGATCCGTTGCTGAAAGTTTTATTTTTGTTTATGCTCAATTAAGAGACTATTACATTCTTATACTAATGTGTTAAAAGTGTGTGTAAAAAGAAGTGTGTGCACAGTGTAAGAAAATGAAATGGTCGGACTTCTAAAAAGAACGTCCTAAAATTCATTAATGATCCTTCCGCAGGTTGACCTACGGAAACCT.(such as SEQ ID NO: 3); Sequencing result is carried out in NCBI website sequence alignment ( http:// blast.ncbi.nlm.nih.gov/Blast.cgi), with little rhodotorula CBS4407 than homology 99%.
Embodiment 2: fungal drug sensitive experiment
With reference to M27-A3 method (Clinical Laboratory and Standards Institute.Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts.Approved standard M27-A3.Wayne, PA:National Committee for Clinical Laboratory Standards, 2008.), this little rhodotorula is measured the drug susceptibility of amphotericin b, flucytosine, fluconazole, itraconazole and voriconazole.Its MIC value is respectively <0.5, <4,16, <0.125, <1 μ g/mL.
More than show and described ultimate principle of the present invention, principal character and advantage of the present invention.The technician of the industry should understand; the present invention is not restricted to the described embodiments; that in above-described embodiment and specification sheets, describes just illustrates principle of the present invention; the present invention also has various changes and modifications without departing from the spirit and scope of the present invention, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.

Claims (4)

1. the little rhodotorula of a strain (Rhodotorula minuta), deposit number is CGMCC No.6019.
2. the separation and Culture purification process of little rhodotorula according to claim 1, is characterized in that, the method comprises:
Little rhodotorula is inoculated in sabouraud's agar flat board, and 25 ℃, the 3rd rhodotorula bacterium colony of innately looking little.
3. the separation and Culture purification process of little rhodotorula according to claim 2, it is characterized in that, the method comprises that to cultivate and preserve step as follows: from-70 ℃ of refrigerators, take out and preserve pipe, be positioned over immediately in 37 ℃ of water-baths and suitably shake 30s, open cryopreservation tube, get on 1 transfering loop bacterium liquid access Sharpe slant medium; During preservation, by bacterium liquid spread plate, after 48 hours, put into 4 ℃ of Refrigerator stores or put into the yeast that contains 25% glycerine that to leach cream peptone liquid nutrient medium-70 ℃ frozen;
Component and the weight percent of described Sharpe slant medium are as follows: glucose 4%, peptone 1%, agar 1.5%, and every 1000ml adds 200mg paraxin, standby after 121 ℃ of sterilizings in 10 minutes;
Component and the weight percent of described yeast leaching cream peptone liquid nutrient medium are as follows: 1% yeast leaches cream, 2% peptone, 2% glucose.
4. the application of little rhodotorula as claimed in claim 1 in screening antifungal drug, is characterized in that, described fungi is mankind's first fungi, and this described antifungal drug is amphotericin b, flucytosine, fluconazole, itraconazole or voriconazole.
CN201210351821.0A 2012-09-19 2012-09-19 Rhodotorula minuta and separating and culturing method and application thereof Active CN102864085B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210351821.0A CN102864085B (en) 2012-09-19 2012-09-19 Rhodotorula minuta and separating and culturing method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210351821.0A CN102864085B (en) 2012-09-19 2012-09-19 Rhodotorula minuta and separating and culturing method and application thereof

Publications (2)

Publication Number Publication Date
CN102864085A CN102864085A (en) 2013-01-09
CN102864085B true CN102864085B (en) 2014-08-27

Family

ID=47443217

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210351821.0A Active CN102864085B (en) 2012-09-19 2012-09-19 Rhodotorula minuta and separating and culturing method and application thereof

Country Status (1)

Country Link
CN (1) CN102864085B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114958632B (en) * 2022-05-24 2023-05-26 鲁东大学 Salt-tolerant rhodotorula parviflora and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046009A (en) * 2008-06-03 2011-05-04 阿奇化工公司 Compositions and methods for nail fungus treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046009A (en) * 2008-06-03 2011-05-04 阿奇化工公司 Compositions and methods for nail fungus treatment

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ANDREW WEINSTEIN等.Topical Treatment of Common Superficial Tinea Infections.《American Family Physician》.2002,第65卷(第10期),2095-2102页.
Chen,M.等.HQ453971.《Genbank》.2011,1页. *
Topical Treatment of Common Superficial Tinea Infections;ANDREW WEINSTEIN等;《American Family Physician》;20020515;第65卷(第10期);2095-2102页 *
临床疑诊甲真菌病1036例真菌学分析;陈丽娜 等;《中国皮肤性病学杂志》;20040430;第18卷(第4期);217-218页 *
周与良 等.抑菌试验用于测定T-2毒素.《微生物学通报》.1990,(第3期),144-146页.
抑菌试验用于测定T-2毒素;周与良 等;《微生物学通报》;19900630(第3期);144-146页 *
陈丽娜 等.临床疑诊甲真菌病1036例真菌学分析.《中国皮肤性病学杂志》.2004,第18卷(第4期),217-218页.

Also Published As

Publication number Publication date
CN102864085A (en) 2013-01-09

Similar Documents

Publication Publication Date Title
Strati et al. Age and gender affect the composition of fungal population of the human gastrointestinal tract
Furbino et al. Diversity patterns, ecology and biological activities of fungal communities associated with the endemic macroalgae across the Antarctic Peninsula
Monteiro et al. Antagonism of Bacillus spp. against Xanthomonas campestris pv. campestris
CN103740618B (en) One Bacillus species novel bacterial and cultural method thereof and application
Leis et al. Finding a robust strain for biomethanation: anaerobic fungi (Neocallimastigomycota) from the Alpine ibex (Capra ibex) and their associated methanogens
Meshram et al. Muscodor kashayum sp. nov.–a new volatile anti-microbial producing endophytic fungus
Song et al. Phylogenetic diversity of thermophilic actinomycetes and Thermoactinomyces spp. isolated from mushroom composts in Korea based on 16S rRNA gene sequence analysis
Montoya et al. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients
de A. Santiago et al. A new species of Lichtheimia (Mucoromycotina, Mucorales) isolated from Brazilian soil
Huai-Gu et al. Composition of wheat rhizosphere antagonistic bacteria and wheat sharp eyespot as affected by rice straw mulching
Pruvost et al. New media for the semiselective isolation and enumeration of Xanthomonas campestris pv. mangiferaeindicae, the causal agent of mango bacterial black spot
CN112143658B (en) Beauveria bassiana strain MQ-08 and application and microbial preparation thereof
Zhang et al. Botrytis pyriformis sp. nov., a novel and likely saprophytic species of Botrytis
Zhang et al. Microdochium paspali, a new species causing seashore paspalum disease in southern China
Beyene et al. Molecular identification and performance evaluation of wild yeasts from different Ethiopian fermented products
CN103184171A (en) Mycoplasma hyopneumoniae DJ-166 strain and application thereof
Wen et al. Onychomycosis associated with Exophiala oligosperma in Taiwan
CN101597581B (en) Bacillus alcalophilus as well as culture method and application
CN102876585A (en) Cryptococcus gattii, and isolated culture method and application thereof
Rodríguez-Andrade et al. A revision of malbranchea-like fungi from clinical specimens in the United States of America reveals unexpected novelty
Chae et al. Rapid direct identification ofCryptococcus neoformans from pigeon droppings by nested PCR usingCNLAC1 gene
Huynh et al. Ethanol production from molasses at high temperature by thermotolerant yeasts isolated from cocoa
Zhang et al. Microcycle conidiation and the conidial properties in the entomopathogenic fungus Metarhizium acridum on agar medium
CN104877940B (en) One plant of streptococcus thermophilus
Jackson Dissolved oxygen levels affect dimorphic growth by the entomopathogenic fungus Isaria fumosorosea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant